A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study



Status:Terminated
Conditions:Obesity Weight Loss
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - Any
Updated:6/29/2018
Start Date:March 2015
End Date:March 8, 2018

Use our guide to learn which trials are right for you!

This is a post-approval, multicenter, prospective, non-randomized, open-label, clinical study
to evaluate the safety and effectiveness of the LAP-BAND® AP System in a lower obese
population (BMI ≥ 30 kg/m2 and < 40 kg/m2) with one or more obesity-related comorbidity up to
10 years after implantation.

The reason your study has been terminated is based on the availability of long-term safety
and effectiveness data from the OSB Lead-HERo-002 study and published literature.

FDA post-approval study designed to collect prospective data in a real-world setting to
evaluate long-term safety and effectiveness of the LAP BAND® System in patients with a BMI of
≥ 30 kg/m2 and < 40 kg/m2 and one or more comorbid conditions. The Apollo-001 Study is a
prospective, 10 year, multicenter study of patients who have decide to undergo implantation
of the LAP-BAND AP® system. Outcomes include device explants, changes in weight, comorbid
condition status, device- and procedure-related AEs, and reoperations.

The LBMI study was part of the condition of approval (CoA) for the Lap-Band device. It was
terminated because it was no longer required to fulfill the condition of approval for the
device. Apollo was able to fulfill the condition of approval (CoA) for the Lap-Band device by
using data from published literature and another recently completed study (OSB Lead-Hero-002
study) which had long-term safety and effectiveness data addressing the conditions of
approval.

Inclusion Criteria:

1. LAP-BAND® System placed in a facility in the United States

2. BMI ≥ 30 kg/m2 and < 40 kg/m2 prior to LAP-BAND® placement

3. Presence of 1 or more obesity-related comorbidities prior to LAP-BAND® placement

4. Aged 18 or older

Exclusion Criteria:

1. Prior bariatric surgery.

2. Participating in another ongoing clinical study in which concomitant diagnostic or
therapeutic intervention that would reasonably be expected to alter patterns of care,
use of medications or the outcomes under study.

3. Vulnerable patients or those unable to exercise free informed consent.

4. Inability to complete the questionnaires.

5. Patients who are addicted to alcohol and/or drugs.
We found this trial at
11
sites
Louisville, Kentucky 40215
?
mi
from
Louisville, KY
Click here to add this to my saved trials
Champaign, Illinois 61820
?
mi
from
Champaign, IL
Click here to add this to my saved trials
Chicago, Illinois 60522
?
mi
from
Chicago, IL
Click here to add this to my saved trials
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
?
mi
from
Draper, UT
Click here to add this to my saved trials
Fountain Valley, California 92708
?
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Metairie, Louisiana 70001
?
mi
from
Metairie, LA
Click here to add this to my saved trials
70 Washington Square S
New York, New York 10012
(212) 998-1212
New York University More than 175 years ago, Albert Gallatin, the distinguished statesman who served...
?
mi
from
New York, NY
Click here to add this to my saved trials
5510 East State Street
Rockford, Illinois 61108
?
mi
from
Rockford, IL
Click here to add this to my saved trials
Rockville, Maryland 20850
?
mi
from
Rockville, MD
Click here to add this to my saved trials
1400 Lemay Ferry Road
Saint Louis, Missouri 63118
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials